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Introduction 1
Cytomegaloviruses (CMVs) are prototypical β-herpesviruses with an enveloped virion 2 coating a large double stranded DNA genome of ~230 kbp which encodes numerous viral 3 proteins. Upon infection, CMVs initiate a sequential and highly coordinated gene expression 4 profile, starting with immediate early (IE) transcripts, followed by early and late gene 5 products -the latter being simultaneously expressed with and depending on genome 6 amplification by rolling circle replication. 7
Although the infection in healthy individuals is mostly asymptomatic due to virus control by a 8 concerted response of the innate and adaptive immune system (1) , primary as well as 9 recurrent CMV infections cause symptomatic or even fatal pathologies in immuno-10 compromised or immature individuals. Irrespective of their robust immune stimulatory 11 capacity, CMVs circumvent sterile immunity and instead establish a lifelong latency. 12
Reactivation occurs upon immuno-suppressing and/or stressful conditions due to (re-) 13 initiation of the lytic viral replication program. Human CMV (HCMV, HHV-5, taxonomy ID: 14 10359) frequently causes congenital infections via a vertical transmission from the mother to 15 the developing foetus and constitutes the most frequent non-genetic congenital complication 16 in western countries (2). 17
CMVs have undergone an intimate and long lasting co-adaptation with their respective host 18 species and are thus highly species-specific, which restricts efficient viral replication to cells 19 of the native host species and thereby excludes experimentation with HCMV in animal 20 models. The related mouse cytomegalovirus [MCMV, Murid herpesvirus 1, taxonomy ID: 21 10366]) has a co-linear and partially homologous genome and infects mice (Mus musculus, 22 taxonomy ID: 10090) allowing to study cytomegaloviral pathogenesis. Additionally, MCMV 23 represents one of the few DNA viruses naturally infecting Mus musculus as its native host and 24 has therefore become a widely used model to explore virus-host interactions and to assess 25 their consequences in vivo. 26
Among the earliest immune responses raised against viruses is the secretion of interferons 27 (IFNs). IFNs are pleiotropic cytokines expressed upon encounter of pathogens or their 28 pathogen-associated molecular patterns (PAMPs). IFNs bind to specific cell surface resident 29 IFN receptors and subsequently induce a rapid janus kinase (JAK) mediated phosphorylation 30 of signal transducer and activator of transcription (STAT) which than instruct specific 31 transcriptional programs to (re-)enforce intrinsic resistance, induce innate immunity and 32 stimulate and recruit adaptive immune responses. Thereby, IFNs orchestrate the induction of 33 an antiviral state that efficiently restricts viral replication (3). 34 Type I IFNs (IFNα/β) mainly induce STAT1 and STAT2 Tyr (Y) phosphorylation (residues 1 Y701 and Y689, respectively) upon binding of the IFN to the heterodimeric IFNAR1-2 IFNAR2 receptor complex and the accompanying activation of the receptor-associated 3 kinases JAK1 and tyrosine kinase 2 (Tyk2). STAT3 becomes also Y-phosphorylated (at 4 residue Y705) by type I IFNs. These STAT Y-phosphorylation events are essential for 5 transcriptional activation of STAT molecules (4-7) and are thus widely considered to 6 constitute a hallmark and faithful surrogate marker for STAT activation. Phosphorylated 7 STAT1 and STAT2 recruit IRF9 to form the IFN-stimulated gene factor 3 (ISGF3), which 8 binds to IFN-stimulated response elements (ISRE) to recruit the transcriptional machinery and 9 stimulate the expression of adjacent genes. In contrast, IFNγ mainly signals via Y-10 phosphorylated STAT1 homodimers which are induced upon binding of IFNγ to the 11 heterodimeric IFNGR1-IFNGR2 receptor and the activation of JAK1 and JAK2. 12
Besides IFNs, STAT3 Y705 phosphorylation is also induced by a broad variety of growth 13 factors and cytokines (e.g. IL-6, IL-10, EGF, LIF, OSM and Leptin). It is noteworthy that 14 STAT3-activating stimuli play an important role in CMV biology. For example, transcripts are strongly induced in HCMV-infected cells (8, 9) stimulating IL-6 secretion (10). 16
Interestingly, recent results document an important regulation of HCMV reactivation by IL-6 17 (11) (12) (13) . Additionally, MCMV induces the expression of IL-10 to suppress MHC class II 18 presentation (14) . HCMV encodes a STAT3-activating IL-10 homolog acquired by molecular 19 piracy (15) . 20
Viruses counteract the antiviral activity of the IFN system by expressing IFN antagonists, 21 targeting e.g. JAK-STAT signal transduction (16, 17) . We have identified and characterized 22 the MCMV-encoded IFN inhibitor pM27. Replication of a M27 deletion virus mutant (∆M27-23 MCMV) is almost not affected in cell culture (18-21) but is highly attenuated in vivo (18, 21) . 24
Using a forward genetic screening approach, we identified pM27 to be an IFN antagonist 25 targeting STAT2 (21) and thereby abrogating the induction of IFN target genes (21, 22) . 26
Consistently, replication of ∆M27-MCMV is highly susceptible to IFNs in cell culture (21, 27 23) . pM27 acts by recruiting cellular DDB1-containing ubiquitin ligase complexes and to 28 proteasomally degrade STAT2 (23). Like MCMV, HCMV also encodes a yet unknown 29 protein inducing proteasomal degradation of STAT2 (24) . 30
Here, we extend our analysis to the interplay between MCMV and further STAT transcription 31 factors present in CMV target cells. Unexpectedly, we found prolonged STAT1 Y-32 phosphorylation and seemingly autonomous STAT3 phosphorylation as consequence of viral 33 JAK-STAT inhibition instead of being a hallmark of STAT activation. 34
Material and Methods: 1
Cells and cytokines 2 NIH3T3 (ATCC CRL-1658), RAW 264.7 (ATCC TIB-71), M2-10B4 (kindly provided by 3 Brendan Marshall [Medical College of Georgia, USA]), mHTC-K2 (25), STAT3 flox/flox , crisis 4 immortalized IFNAR1-(26), respective C57BL/6 control fibroblasts, STAT3-(27), JAK2-5 (28), IL-6-and primary IL-10-deficient (prepared as described (29)) fibroblasts were grown in 6
Dulbecco's modified eagle medium (D-MEM) with 10% (vol/vol) foetal bovine serum (Gibco 7
[Invitrogen]), streptomycin, penicillin and 2 mM glutamine. 8
IFNs (mouse IFNα (#12100-1) and mouse IFNγ (#12500-1)) were purchased from PBL 9 Biomedical Laboratories, New Jersey, USA. If not stated otherwise, cells were treated with 10 500 U/ml IFN. Hyper-IL-6 has been described previously (30). 11
12

Viruses, infection conditions and virus titration 13
Preparation, purification and titration of MCMV stocks was done as described previously (21, 14 26, 31) . wt-MCMV and ∆M27-MCMV have been described previously (21) . For the 15 construction of ∆m157-MCMV:mCherry, a frt-site-flanked fragment encompassing the 16 HCMV-derived major IE promoter/enhancer (MIEP) in front of the mCherry gene was 17 introduced into a recombinant MCMV bacterial artificial chromosome (which already 18 harbored a frt site instead of the m157 CDS) by flp-mediated recombination. UV inactivation 19 was conducted with indicated J/m 2 doses of UV irradiation in a CL-1000 UV cross-linker 20 (UVP). 21
22
Electromobility shift assay (EMSA) 23
Extraction of fractionated EMSA lysates and the EMSA assay was performed as described 24 (26 phenylmethylsulfonyl fluoride (PMSF), 1 µg/ml leupeptin, 1 µg/ml pepstatin, 50 mM NaF, 10 0.1 mM Na-vanadate with Complete ® protease inhibitors [Roche] pH 7.5). Samples were 11 normalized according to Bradford protein staining and equal amounts were subjected to 12 denaturing SDS-PAGE. Gels were blotted on nitrocellulose membranes (GE Healthcare) and 13 probed with indicated antibodies. The same membrane was used and consecutively stripped 14 with reblot solution (Millipore). The following antibodies were used: α-β-actin from Sigma-15 -21) , and α-IRF-1 (M-20) from Santa Cruz; 17 α-phospho-Y701 STAT1, α-phospho-S727 STAT1, α-phospho-S727 STAT3 and α-Lamin 18 A/C from Cell Signaling, α-SOCS3 (ab16030) from Abcam. α-pp89-IE1 (Croma101) and α-19 pM45 were provided by Stipan Jonjić, University of Rijeka, Croatia. The actual MCMV 20 antigen of the α-pM45 was defined by co-immuno-precipitation and mass-spectrometry by 21 Gabriela E. Androsiac, HHU Düsseldorf, Germany. Quantification of immunoblot signals was 22 conducted using a Fusion FX7 (Vilber Lourmat). 23
24
Luciferase Assay 25
For reporter gene assays, a NIH3T3-derived cell line harbouring a GAS luciferase vector was 26 selected. To do so, a fragment comprising the promoter/enhancer sequence and the fire fly 27 (Photinus pyralis) luciferase gene from the pTA-GAS construct (Clontech) was sub-cloned 28 into a pGene vector backbone conferring Zeocine resistance (Invitrogen). Cells were induced 29 with 100 U/ml of the indicated recombinant mouse IFN. Luciferase activity was measured 30 using the luciferase reporter gene assay, high sensitivity according to the manufacturer's 31 instructions (Roche) using a microplate luminometer (model LB 96V; Berthold). 32
33
Northern blot analysis of specific transcripts 34 Total RNA was extracted from cells using the RNeasy Mini Kit (Qiagen). Total RNA was 1 subjected to MOPS gel electrophoresis and transferred to nylon membranes using the 2 TurboBlotter (Schleicher and Schuell). Probes were prepared by PCR with gene-specific 3 primers (Table 1 ) and digoxigenin-labelled dUTP (Roche) for detection of indicated 4
transcripts. Hybridization and detection were performed as described in Roche manuals. 7.5 and 20 mM Na-butyrate) and buffer 2 (400 mM NaCl, 2 mM EDTA, 0.5 mM EGTA, 20 30 mM HEPES pH 7.5 and 20 mM Na-butyrate). Cells were lysed in lysis buffer (150 mM NaCl, 31 25 mM Tris pH 7.5, 5 mM EDTA, 1% [vol/vol] Triton-X-100, 0.1% [weight/vol] SDS, 0.5% 32 [weight/vol] Na-deoxycholate, 1 mM PMSF, 10 mM Na-butyrate and Complete protease 33 inhibitors (Roche). Lysates were sonicated (5 cycles [2 min each]; amplitude 30; cycle 0.5 on 34 ice in a Sartorius Labsonic P) and subsequently cleared by centrifugation. Supernatants were 1 pre-cleared by addition of protein G sepharose (PGS) in presence of 100 µg/l salmon sperm 2 DNA and 500 µg/l BSA. After the pre-clearing procedure, an aliquot was stored ('input'). 3
Precipitation was performed over night at 4°C using a STAT1-specific antibody (E-23; Santa 4 Cruz). Immune complexes were precipitated using PGS (1-2 h at 4°C). Afterwards, the 5 sepharose was washed twice with RIPA buffer (150 mM NaCl, 50 mM Tris pH 8.0, 0. Intrigued by the central role of STAT1 for type I and type II IFN signalling, we investigated 4 the interplay between MCMV and STAT-activation by IFNs. In clear contrast to STAT2, 5 which is rapidly degraded upon MCMV infection (21, 23), STAT1 protein amounts remained 6 stable in MCMV-infected cells (Fig. 1A ). STAT1 Y701 phosphorylation was virtually absent 7 in untreated cells but became strongly induced upon exposure to IFNγ (Fig. 1A) . A 8 comparable IFNγ-induced STAT1 phosphorylation was also evident in MCMV-infected cells 9 ( Fig. 1A) indicating that IFNGR proximal events of JAK-STAT1 signalling are not affected 10 by MCMV-encoded IFN antagonists. Nuclear translocation of STAT1 was also not inhibited 11 by MCMV since equal amounts of phosphorylated STAT1 were detected in nuclear lysates of 12
IFNγ-incubated MCMV-infected cells and mock control cells ( Fig. 1A , right panel). 13
Consistently, the nuclear translocation of transiently transfected GFP-tagged STAT1 was not 14 compromised upon MCMV infection (Fig. 1B) . The analysis of the DNA-binding capacity of 15 STAT1 by electro-mobility shift assay (EMSA) revealed that STAT1:STAT1 homodimers 16 retained their capacity to bind to gamma activated sequence (GAS) DNA elements after 17 MCMV infection -irrespective of M27 coding capacity (Fig. 1C ). Chromatin 18 immunoprecipitation (ChIP) experiments confirmed the intact ability of STAT1 to bind to 19 endogenous GAS DNA elements (here the irf-1 promoter) in MCMV-infected cells upon 20 IFNγ exposure ( Fig. 1D ). To test the ability of MCMV to antagonize GAS-dependent gene 21 expression, we constructed a stable MCMV-permissive NIH3T3 cell line harbouring the 22 firefly (Photinus pyralis) luciferase reporter gene under the control of a minimal promoter 23 and a GAS enhancer element. In mock-infected cells, IFNγ strongly induced luciferase 24 activity, but the response was significantly inhibited upon MCMV infection -again 25 irrespective of M27 coding capacity ( Fig. 1E ). To rule out that this effect is influenced by 26 previously observed effects of CMV infections on gene expression derived from reporter 27 plasmids (34), we studied the ability of MCMV to counteract the IFNγ-dependent induction 28 of endogenous IRF-1 mRNA by northern blotting. 4 h of MCMV infection already sufficed to 29 antagonize IFNγ-induced IRF-1 transcription (Fig. 1F ). These results demonstrate that 30 MCMV abrogates IFNγ-induced gene expression without compromising overall STAT1 31 protein amounts, receptor-proximal Y701 STAT1 phosphorylation, nuclear translocation of 32 STAT1 or the capability to bind to DNA -largely confirming previous reports (35). 33
Additionally, our results reveal that this inhibition is not influenced by pM27, documenting 34 the existence of at least one additional MCMV-encoded antagonist of JAK-STAT signal 1 transduction. 2 3
MCMV gene expression induces IFNAR1-independent STAT3 phosphorylation 4
Given that STAT1 and STAT3 are highly homologous proteins (53% identical and 72% 5 similar) and that STAT3 transduces signals of pro-as well as anti-inflammatory cytokines 6 that play a crucial role in CMV immune control and pathogenesis (11) (12) (13) (14) , we extended our 7 analysis to STAT3. In contrast to STAT1, a basal STAT3 Y705 phosphorylation was 8 frequently (depending on exposure time of the films) observed in untreated, mock-infected 9 cells. Nevertheless, we observed a substantial increase of STAT3 Y705 phosphorylation upon 10 MCMV infection ( Fig. 2A-C) . Surprisingly, global STAT3 protein amounts simultaneously 11 declined in MCMV-infected cells as revealed by two different STAT3-specific antibodies 12 recognizing different parts of STAT3 ( Fig suggesting that the phosphorylation event does not preclude STAT3 recognition by the used 20 antibodies (C-20 and K-15). To confirm the detected protein band to represent truly STAT3, 21
we performed an experiment in STAT3-deficient cells. We observed STAT3 phosphorylation 22 upon MCMV infection in STAT3-positive cells, but no signal was detectable in STAT3-23 deficient cells ( Fig. 2B ). Since the respective membranes were probed in a sequential manner, 24 STAT3 was also detected on separate membranes by different antibodies in parallel to ensure 25 that such procedure does not mask secondary STAT3 detection. We reproduced increased 26 levels of Y705 phosphorylation despite an overall reduction of STAT3 protein amounts in 27 MCMV-infected cells (Fig. 2C ). The decrease of STAT3 and the parallel increase of 28 phosphorylated STAT3 was quantified ( Fig. 2D ). An increasing MCMV infection dose was 29 directly positively correlated with STAT3 Y705 phosphorylation as well as reduction of the 30 overall STAT3 protein amount ( Fig. 2E ). 31
Among other cytokines and growth factors, IFNα is known to induce STAT3 phosphorylation 32 (36). This effect was also observed in MCMV-permissive NIH3T3 cells ( Fig. 2F ). Since 33 MCMV infection initially induces type I IFN production (31), we used IFNAR1-deficient 34 cells to test if the observed STAT3 phosphorylation is caused by type I IFN. STAT3 1 phosphorylation and reduction of STAT3 protein amounts were observed with almost 2 congruent kinetics in IFNAR1-deficient and identically immortalized C57BL/6 fibroblasts 3 ( Fig. 2G ), indicating that both effects on STAT3 are To analyse if viral gene expression is required for STAT3 modulation, NIH3T3 cells were 5 infected with MCMV virions which had been inactivated with grading UV doses (250 -6 10,000 J/m 2 ). Subsequently, STAT3 phosphorylation and global STAT3 protein amounts 7 were assessed by immunoblot. UV-inactivation of viral gene expression, as documented by 8 pp89-IE1 detection, abrogated STAT3 phosphorylation and reduction ( Fig. 2H ), indicating 9 that cytomegaloviral gene expression is essential for the observed modulation of STAT3. 10
We also detected STAT3 phosphorylation upon reversible application of protein synthesis 11
inhibitor Cycloheximide (CHX) followed by Actinomycin D (ActD) inhibition of 12 transcription leading to MCMV gene expression restricted to immediate early (IE) gene 13 products (37). However, this result cannot be interpreted as a proof for the responsibility of 14 viral IE genes due to similar drug-induced changes in STAT3 phosphorylation levels in UV-15 MCMV as well as mock-infected cells (data not shown). A previously described fibroblast 16 cell line stably transfected with the IE gene region encompassing the respective HindIII 17 fragment of MCMV and thus being able to complement the growth of MCMV mutants 18 lacking the essential gene ie3 (38), did not exhibit overt STAT3 phosphorylation or reduced 19 STAT3 protein amounts in comparison to parental NIH3T3 cells (data not shown), suggesting 20 that ie gene expression is not sufficient for the observed changes of STAT3. 21
To evaluate whether MCMV late gene expression is required for the effects on STAT3, we 22 infected cells in the presence of ganciclovir (GCV) -a drug which interferes with MCMV 23 DNA replication and thereby strongly reduces the accompanying viral late gene expression. 24
Late gene expression was neither essential for the phosphorylation of STAT3 nor for the 25 reduction of STAT3 overall amounts ( Fig. 2I ). Taken together, these results reveal that (a) 26
MCMV IE-and/or early-expressed gene product(s) induce(s) a sustained STAT3 27 phosphorylation and simultaneously reduce(s) STAT3 overall amounts. 28
29
The MCMV-induced STAT3 Y705 phosphorylation occurs independent of IL-6, IL-10, gp130 30 and JAK2 and is restricted to infected cells 31
As mentioned above, MCMV induces cytokines like IL-6 and IL-10, which mainly signal via 32
STAT3. Therefore, we tested if these cytokines are involved in the MCMV-induced STAT3 33 Y705 phosphorylation. Fibroblasts deficient for IL-6 and IL-10, respectively, both exhibited 34 STAT3 phosphorylation upon MCMV infection (Fig. 3A) , indicating that these interleukins 1 are not essential for the observed phosphorylation. Since JAK2 is known to be crucial for the 2 signalling of a variety of cytokine receptors (28, 39), we assessed JAK2-deficient fibroblasts, 3 but again we observed STAT3 phosphorylation upon MCMV infection (Fig. 3A) . However, 4
we could not exclude the possibility that STAT3 phosphorylation results from redundant 5 signalling via several receptors. Paralleling STAT3 phosphorylation, the reduction of the 6 overall STAT3 protein amount was also evident in the three gene-deficient cells and the 7 control fibroblasts (Fig. 3A) . 8 STAT3 can be phosphorylated by cytokines via receptor bound janus kinases but also by 9 growth factors via receptor tyrosine kinases (RTKs) and by cytoplasmic kinases like c-Src 10 (40) and 42) . Several STAT3-activating cytokines signal via a heterodimeric 11 receptor complex composed of a cytokine-specific subunit and the gp130 signalling module. 12
Soluble gp130-Fc blocks gp130-dependent IL-6 signalling and to a lesser extent LIF and 13 OSM signalling (43). Therefore, we used commercially available soluble gp130-Fc, to test the 14 involvement of gp130 in MCMV-induced STAT3 phosphorylation. As expected, soluble 15 gp130 blocked Hyper-IL-6-dependent STAT3 activation, but the STAT3 phosphorylation by 16 MCMV was not impaired (data not shown). 17
Next, we transferred conditioned medium (sterile-filtered or UV-inactivated) from MCMV-18 infected NIH3T3 cells (which exhibited substantial STAT3 phosphorylation) to uninfected 19 fibroblasts and RAW 264.7 macrophages, respectively. Conditioned medium did not induce 20 STAT3 phosphorylation above background in fibroblasts or RAW cells ( Fig. 3B) . 21
Subsequently, we conducted transwell experiments in which MCMV-infected and uninfected 22 cells continuously share the same medium. Again, STAT3 phosphorylation was only 23 observed in infected cells but not in uninfected bystander cells ( Fig. 3C ), suggesting that the 24 STAT3 Y705 phosphorylating principle is restricted to infected cells and not transferable to 25 neighbouring cells when MCMV transmission is prevented. From these data we assume that 26 STAT3 phosphorylation does not require a secreted factor released from infected cells, 27 although we cannot formally rule out the implication of membrane bound cytokines (like for 28 example the tumour necrosis factor (TNF) superfamily member LIGHT which has been 29 shown to induce STAT3 phosphorylation (44)). 30
Under standard (non-serum-starved) culture conditions, cells are constantly exposed to 31 growth factors present in the foetal bovine serum contained in the cell-culture media. Several 32 growth factors (e.g. basic fibroblast growth factor (45) and insulin-like growth factor I (46)) 33 have been demonstrated to induce STAT3 phosphorylation. We therefore tested if and how 34 such growth factors influence the MCMV-induced STAT3 phosphorylation. Even though 1 STAT3 phosphorylation was restricted to cells being MCMV-infected and was not 2 transmitted to bystander cells (see above), we found that increasing foetal bovine serum 3 (FBS) present in the cell culture medium concentration-dependently enhanced STAT3 4 phosphorylation in MCMV-infected cells (Fig. 3D -for a discussion of this finding see 5 below). 6
Taken together, MCMV induces STAT3 phosphorylation in infected cells by an IFNAR1-, 7 IL-6-, IL-10-, gp130-and JAK2-independent principle which is restricted to infected cells. In 8 addition, growth factors present in the cell culture media (e.g. FBS) have the potency to 9 further enhance STAT3 phosphorylation in MCMV-infected cells. 10 11
MCMV interferes with STAT1 and STAT3-dependent gene expression 12
Based on our finding that tyrosine phosphorylated STAT1 molecules are transcriptionally 13 inert in MCMV-infected cells (Fig. 1) , we raised the question if MCMV-induced Y705 14 phosphorylated STAT3 is actually active in terms of target gene expression. To this end we 15 chose the canonical target gene SOCS3 encoding an immediately responsive and highly 16 sensitive surrogate marker protein of STAT3 function. Cells were infected with MCMV and 17 24 h post infection treated with Hyper-IL-6 and IFNγ, respectively. Interestingly, despite 18 efficient induction of Y705 phosphorylated STAT3 in MCMV-infected cells, we did not 19 observe the expected increase of SOCS3 amounts. On top of that, an additional stimulation 20
with Hyper-IL-6 or IFNγ, which strongly induces SOCS3 in mock cells, failed to induce 21 SOCS3 in MCMV-infected cells (Fig. 4A ). Adequate MCMV infection was documented by 22 detection of pp89-IE1 and equal protein loading by detection of β-actin. As expected, MCMV 23 infection resulted in reduced STAT3 protein amounts (Fig. 4A) . 24
To test if the blockade of the SOCS3 response is specific or part of a general inhibition and 25 whether it is executed on transcriptional level or acts post-transcriptionally, we performed 26 northern blot experiments. We found that MCMV infection drastically inhibited the induction 27 of SOCS3, SOCS1, IRF-1 and cEBPδ transcripts by IFNγ and the induction of multiple 28 STAT3 target genes including SOCS3, IRF-1, cEBPδ, JunB and c-Myc by Hyper-IL-6 ( Fig.  29   4B) . 30
In this context, it is noteworthy that it is well documented that an auto-regulative STAT3 31 circuit exists since STAT3 gene transcription is . Thus, the decline 32 of STAT3 protein amount might represent a consequence of the cytomegaloviral disruption of 33 canonical STAT3-dependent signal transduction and gene expression. Therefore, we tested 34 the expression of STAT3 mRNA and found it to be significantly reduced upon MCMV 1 infection (Fig. 4B ). In summary, MCMV interferes with STAT1 and STAT3 signal 2 transduction, leading to impaired target gene induction. 3
To reach the maximal rate of transcriptional activity, certain STAT molecules (including 4 STAT1 and STAT3) require additional phosphorylation of serine residue 727 (50). Since our 5 data uncover a MCMV-encoded inhibition of STAT1 and STAT3 target gene expression at a 6 step beyond tyrosine phosphorylation, we assessed Ser727 phosphorylation of STAT1 and 7 STAT3 in MCMV-infected cells upon treatment with IFNγ or Hyper-IL-6. We found that the 8 IFNγ-induced Ser727 phosphorylation was not inhibited by MCMV (Fig. 5 ). MCMV 9 infection did also not significantly change the level of constitutive Ser727 STAT3 10 phosphorylation in unconditioned cells (Fig. 5) . Nevertheless, the Hyper-IL-6-induced 11 increase in Ser727 phosphorylation of STAT3 was to a certain extent reduced in MCMV-12 infected cells (irrespective of M27 coding capacity) compared to mock-infected cells or cells 13 infected with UV-irradiated MCMV (Fig. 5 ). We interpret this minor change in Ser727 the question whether the MCMV-encoded inhibitor, which acts on the level of transcriptional 23 activation after effected phosphorylation, would prevent the expression of negative feed-back 24 regulators and thereby counterintuitively prolong IFNγ-induced STAT1 phosphorylation. To 25 test this hypothesis, we pulse stimulated infected or non-infected cells for a short period (30 26 min) with IFNγ. Afterwards, we vigorously washed the cells to remove the IFNγ and then 27 followed the slope of declining STAT1 phosphorylation levels over a period of 8 h. As shown 28 in Fig. 6 , STAT1 phosphorylation was virtually undetectable in untreated cells but readily 29 observed after adding IFNγ. In mock infected cells, STAT1 phosphorylation declined within 4 30 h. Conversely, in MCMV-infected cells a substantial amount of phosphorylated STAT1 was 31 still apparent after 8 h. M27 coding capacity did not affect this prolongation of STAT1 32 phosphorylation. We concluded that MCMV interferes with IFNγ-induced gene expression on 33 the transcriptional level downstream of STAT1 Y701 phosphorylation resulting in abrogation 34 of the induction of the negative feedback loop (e.g. SOCS1 expression) leading to prolonged 1 STAT1 phosphorylation upon incubation with IFNγ. 2 3 Neither pIE1pp89 nor pM27 are essential for the cytomegaloviral STAT3 regulation 4 HCMV IE1-pp72 has been described as inhibitor of IFN-JAK-STAT signalling which 5 antagonizes ISRE signal transduction and simultaneously induces GAF-like responses (51, 6 52) . Despite the limited primary sequence conservation between HCMV IE1-pp72 and 7 MCMV IE1-pp89 (~22% identity and ~42% similarity within a ~190 amino acid stretch 8
[residues 23-197 in HCMV IE1-pp72 and 33-210 in MCMV pp89-IE1, respectively]), the 9 MCMV homolog IE1-pp89 was found to co-precipitate with human STAT2 (53) defining 10 MCMV-pIE1 as potential candidate for a STAT-specific IFN antagonist. Therefore, we tested 11 if the STAT3 phosphorylation, reduction of the overall STAT3 amount and the inhibition of 12 target gene expression are preserved in cells infected with an MCMV mutant lacking the ie1 13 coding capacity. All three effects were found to be independent of ie1 (Fig. 7A) . 14 Besides pIE1-pp72, the only other known cytomegaloviral antagonist of JAK-STAT signal 15 transduction is pM27 (54). Consequently, we tested if M27 is required for STAT3 16 modulation. But ∆M27-MCMV was also fully capable to stimulate STAT3 phosphorylation, 17 reduced overall STAT3 amounts and antagonized SOCS3 expression ( Fig. 7B) . These results 18 rule out an essential contribution of M27 to the herein described regulation of STAT3 signal 19 transduction and the accompanying inhibition of target gene induction. 20
21
MCMV reveals a dynamic equilibrium of STAT3 activation and deactivation 22
MCMV interferes with STAT1-and STAT3-dependent gene expression in a strikingly similar 23 manner. In both cases, the expression of target genes is antagonized on the transcriptional 24 level despite the nuclear presence of Tyr-phosphorylated STATs. The lack of target gene 25 expression includes the well-known negative feedback regulators SOCS1 and SOCS3, 26 explaining the exaggerated tyrosine phosphorylation. Nevertheless, STAT1 phosphorylation 27 is prolonged but requires the external stimulus IFNγ, whereas STAT3 phosphorylation is 28 seemingly 'autonomous'. How can this apparent difference be reconciled? We hypothesize 29 that cell culture media including FBS contains stimuli like growth factors which induce low-30 level of `constitutive` STAT3 Y705 phosphorylation. These growth factors induce STAT3 31 phosphorylation which stimulates gene expression including the STAT3-dependent mediators 32 of the negative feedback (e.g. SOCS3) constantly balancing phosphorylated STAT3 at low 33 level. Consistently, cre-recombinase induced SOCS3 excision has been found to lead to 34 increased levels of tyrosine-activated STAT3 (55). To test if such a low level STAT3 1 activation exists in MCMV-permissive cells, we used the broad spectrum phosphatase 2 inhibitor sodium vanadate to interfere with STAT3 de-phosphorylation. A 15 min treatment 3 leading to a blockade of cellular phosphatases already induced accumulation of 4 phosphorylated STAT3 eventually resulting in SOCS3 protein induction (Fig. 8A ). This 5 finding indicates that a fine-tuned dynamic equilibrium of STAT3 phosphorylation, gene 6 expression of negative feed-back regulators and subsequent dephosphorylation of STAT3 7 exists in MCMV-permissive cells and that uncoupling of activation and subsequent negative 8 feed-back inhibition results in accumulating phospho-STAT3. We made further use of this 9 sodium-vanadate-mediated uncoupling to induce a long-term 'tyrosine phosphorylation state' 10 and the accompanied SOCS3 induction in cells. Consistent with general inhibition of STAT3 11 target gene expression, MCMV-infection also precluded SOCS3 and IRF-1 protein expression 12 upon long-term sodium-vanadate incubation (Fig. 8B) . 13
Taken together, the herein described MCMV-encoded STAT3 inhibition reveals the existence 14 of a dynamic equilibrium of STAT3 by uncoupling phosphorylation and induction of 15 mediators of the negative feed-back loop. 16
Discussion: 1
We found that MCMV induces seemingly cytokine-autonomous STAT3 phosphorylation. 2 STAT3 phosphorylation is essential for STAT3 activation and thus considered to constitute a 3 faithful surrogate marker for transcriptional STAT3 activity. Although STAT3 is known to 4 stimulate its own transcription (47-49), STAT3 phosphorylation in MCMV-infected cells was 5 accompanied by a reduction of overall STAT3 amounts. This contradiction led to the finding 6 that even a strong external stimulation like Hyper-IL-6 failed to induce all tested STAT3 7 target genes in MCMV-infected cells, documenting the existence of a potent MCMV-encoded 8 antagonist of STAT3 signal transduction. A comprehensive molecular analysis revealed that 9 MCMV interferes with STAT1-and STAT3-dependent signalling after effected tyrosine 10 phosphorylation, thereby also compromising the intrinsic negative feedback loop otherwise 11 executed by proteins like SOCS1 and SOCS3. Due to the lack of these negative regulators, 12 the dynamic equilibrium of STAT phosphorylation and subsequent inactivation is uncoupled 13 upon MCMV infection, leading to the accumulation of transcriptional inactive phospho-14 STAT3. The on-rate of the intrinsic equilibrium is influenced by growth factors present in the 15 cell culture medium and especially the FBS. Therefore, increasing FBS concentrations dose-16 dependently increase STAT3 phosphorylation in MCMV-infected cells. 17
In contrast to STAT3, which is activated by a broad variety of cytokines, interleukins and 18 growth factors, only very few cytokines e.g. IFNs and IL-35 (56) critically rely on STAT1. 19 Therefore, STAT1 phosphorylation is not induced by constituents of serum and untreated 20 cells virtually do not phosphorylate STAT1 and therefore no accumulation can be observed 21 upon MCMV infection alone. Nevertheless, once the cell encounters STAT1-activating 22 cytokines like IFNγ, STAT1 phosphorylation is also prolonged in MCMV-infected cells, yet 23 it remains transcriptionally inert. 24
25
STAT tyrosine phosphorylation -a true hallmark for transcriptional activity? 26
Under normal conditions, phosphorylation of STAT1 and STAT3 at Y701 and Y705, 27 respectively, is undoubtedly crucial for STAT activation. Since highly specific antibodies are 28 available, the determination of the phosphorylation status represents a widely applied way to 29 assess activity of STATs. Our data uncover a biological condition (i.e. virus infection) which 30 challenges the view that tyrosine phosphorylated STATs are necessarily transcriptional active. 31
This example of stalled STAT transcription complexes demonstrates the necessity to conduct 32 further experiments to unequivocally prove the transcriptional activity of tyrosine 33 phosphorylated STAT molecule species. Textbook schemes usually simplify JAK-STAT 34 signal transduction by only depicting STAT factors binding to respective DNA enhancer 1 elements directly resulting in target gene expression. Apparently, the process of 2 transcriptional initiation and transcription by STATs is a highly regulated process requiring 3 precisely choreographed activity of multiple proteins like co-activators, the mediator complex 4 and the RNA polymerase II complex (see for example (57, 58) ). Our data indicate that 5 MCMV interferes with at least one factor involved in this step of regulation. 6 7 Implications for ∆M27-MCMV pathogenesis 8
We have previously described the MCMV-encoded protein pM27 as potent STAT2-specific 9 IFN antagonist (21-24) which interferes with type I IFN signal transduction by inducing rapid 10 proteasomal degradation of STAT2 via recruiting STAT2 to DDB1-containing ubiquitin 11 ligase complexes (23). In absence of M27, MCMV hardly interferes with IFNα-dependent 12 gene expression (21), strongly suggesting that pM27 is essential and sufficient to antagonize 13 formation of functional ISGF3 (STAT2:STAT1:IRF9) complexes. Here, we have 14 characterized a second M27-independent MCMV-encoded antagonism targeting both STAT1 15 and STAT3 signalling. Together both inhibitors preclude type I and type II IFN responses. 16
The presence of IFNα-dependent gene expression observed in ∆M27-MCMV-infected cells 17 together with the pronounced IFN susceptibility of ∆M27-MCMV in vitro and in vivo (21-23) 18 indicate that the herein described second MCMV-encoded IFN antagonist does not (or only to 19 a limited degree) affects ISGF3 complexes and that both MCMV-encoded inhibitors possess 20 non-redundant functions. 21
∆M27-MCMV replication is over-proportionally susceptible to IFNα, but replication is 22 almost completely abrogated in IFNγ-conditioned cells (21). This might be in part explained 23 by IFNγ-dependent STAT2 phosphorylation (21, 59, 60) but IFNγ-induced Y689 STAT2 24 phosphorylation is less pronounced compared to stimulation by type I IFNs, yet the antiviral 25 effect of IFNγ is more potent (21). Our data reveal that phosphorylated STAT3 and STAT1 26 (in presence of IFNγ) accumulate in MCMV-infected cells but remain transcriptionally inert. 27
In the wt-MCMV infection scenario, STAT2-dependent gene expression is abrogated by 28 pM27-dependent STAT2 degradation. Upon ∆M27-MCMV infection, increased and 29 prolonged tyrosine phosphorylation of STAT3 and STAT1, respectively, join STAT2 which 30 seems to bypass the second inhibitor of STAT1 signalling. Together these STATs induce an 31 'overshooting' antiviral state via trans-signalling from IFNγ to ISRE-driven ISGs. 32 33 As outlined above, the biological phenotype of ∆M27-MCMV and the results of our 1 molecular analysis of the JAK-STAT signalling events in MCMV-infected cells indicate that 2 ISGF3 complexes are rather resistant against the herein described cytomegaloviral inhibitor, 3 whereas STAT1 and STAT3 homodimers are sensitive. Such a differential inhibition can only 4 be explained if we infer that the (co-) transcription factor complexes (e.g. p300, CBP, the 5 mediator complex and others) recruited by ISGF3 significantly differ from the complexes 6 utilized by STAT1 and/or STAT3 homodimers. 7 STAT1 is absolutely essential for the generation of functional ISGF3 complexes and thus type 8 I IFNs fail to induce gene expression in STAT1-deficient cells. Nevertheless, a full length 9 transactivation domain (TAD) of STAT1 seems not to be required for ISGF3 signalling: The 10 short splice isoform of STAT1 (STAT1β) lacks large parts of the C-terminal STAT1 TAD 11
and is insufficient to generate transcriptionally active STAT1 homodimers. However, 12 functional ISGF3 complexes can be formed by this STAT1β splice isoform (61). Thus, the 13 transcriptional activation of ISGF3 relies on the TAD of STAT2 whereas the transcriptional 14 activation of STAT1 homodimers depends on the TAD of STAT1. Consistently, specific co-15 regulatory proteins have been described. For example, N-myc and STAT interactor (Nmi) 16 potentiates STAT-dependent gene expression. Interestingly, Nmi binds all STATs except 17 STAT2 (62). Additionally, ISGF3 signalling has been shown to require an interaction with the 18 mediator complex. In this context, STAT2 physically interacts with the mediator components 19 DRIP77 and DRIP150, but none of the tested mediator complex components co-precipitates 20 with STAT1 or STAT3 (57). 21
We infer that the suspected cytomegaloviral inhibitor of JAK-STAT signalling targets a 22 specific (co-) transactivator involved in STAT1 and STAT3 signalling, which is dispensable 23 (or redundant) in terms of ISGF3 signal transduction. 24 25
Potential biological implications for the viral inhibition of STAT3 signalling 26
Given the wealth of knowledge concerning IFN-induced effector mechanisms directly or 27 indirectly interfering with viral replication, the existence of viral antagonists targeting STAT1 28 can easily be understood (54). Less obvious is the 'rationale' behind the herewith described 29 viral modulation of STAT3 signal transduction, especially because several viruses (e.g. Rous 30
Sarcoma Virus, Hepatitis C Virus, Herpesvirus Saimiri, Epstein-Barr Virus and Kaposi's 31
Sarcoma-associated Herpesvirus) encode proteins which induce genuine STAT3 activation 32 (63-67). Nevertheless, other viruses besides MCMV also inactivate STAT3, e.g. mumps virus 33 induces proteasomal degradation of STAT3 (68). This divergence might be based on 34 differences in the viral life styles and authentic STAT3 activation may be correlated with cell 1 transforming potential. 2 A simple explanation for STAT3 inactivation would be that MCMV targets STAT1 and that 3 STAT3 inhibition represents merely a 'collateral damage' resulting from overlapping 4 transcriptional co-activators used by both STATs. We favour the interpretation that STAT3 5 modulation constitutes a selective advantage for MCMV on its own. Recently, it was shown 6 that IL-6 induces PML expression via STAT3 (69). PML is well known to restrict herpesvirus 7 replication (70) which drove HCMV to evolve specific antagonists (71). Therefore, one 8 explanation for the blockade of STAT3 signal transduction might be interference with the 9 induction of antiviral proteins like PML. 10
But why should MCMV retain STAT3 phosphorylation? MCMV infection leads to 11 dramatically increased IL-6 secretion (72) and it has been shown that in absence of STAT3, 12 IL-6 induces STAT1 activation and initiates IFNγ-like responses (73) . Thus, it is tempting to 13 speculate that MCMV invented this elaborated interference with STAT3 signalling (instead of 14 e.g. STAT3 degradation) to avoid that IL-6 in turn induces an IFNγ-like antiviral program. 15
Even though phosphorylated STAT3 is transcriptionally inert in terms of canonical STAT3 16 signal transduction and fails to induce classic target genes (e.g. SOCS3), it might nevertheless 17 fulfil other pro-viral functions in MCMV-infected cells. In this respect, it is noteworthy that 18 the HCMV-encoded IE1-pp72 utilizes phosphorylated STAT1 to elicit an IFN-like host cell 19 response (51) and that the HCMV major IE promoter (MIEP) contains IFN-responsive 20 promoter elements (called VRS1) which resemble STAT-binding sites (or GAS elements) 21 (74). It remains to be elucidated whether phosphorylated STAT3 binds to the MCMV genome 22
to modulate viral gene expression. 23 24
Implications for the interpretation of CMV-induced and CMV-expressed cytokines 25
CMVs induce cellular interleukins like IL-6 and IL-10 whereas HCMV even encodes 26 different splice isoforms of a viral IL-10 homolog. IL-6 and IL-10 signal via STAT3, 27 therefore an inhibition of STAT3-dependent signal transduction has considerable implications 28 for the interpretation of viral cytokine induction. Our results show that cells (e.g. fibroblasts) 29 which are productively infected by MCMV do not respond with a canonical STAT1/3 30 signalling. Therefore, secretion of STAT3-activating cytokines induced by CMV either have 31 to bypass the described inhibition or the cytokines exclusively act in a paracrine manner to 32 manipulate uninfected bystander cells. This interpretation is consistent with findings showing 33 that conditioned media derived from MCMV-infected cells induced MHC class II down 34 regulation upon transfer to uninfected cells in an IL-10-dependent manner (14). Additionally, 1 the expression of the viral STAT3 antagonists will most likely occur delayed in less 2 permissive cells (e.g. macrophages) so that STAT3-dependent signalling of cytokines like IL-3 10 is preserved longer to execute the observed autocrine MHC II down modulation. 4 5 An additional MCMV-encoded IFN antagonist 6
Besides the implications for the understanding of phosphorylated STAT molecules and their 7 feedback regulation, our data reveal the existence of a yet unknown IFN antagonist encoded 8 by MCMV in addition to pM27. This inhibitor targets STAT1/3-dependent gene expression 9 on the transcriptional level without disturbing STAT1/3 phosphorylation. Our future work 10 will be focused on the elucidation of the identity of this particular viral inhibitor. MT, VTKL and HH wrote the paper. 5 6 17. Trilling, M., and H. Hengel. 2013 incubated for 30 min with mouse IFNγ (500 U/ml) and fractionated protein lysates (cytoplasm 5 versus nucleoplasm) were prepared, normalized and subjected to SDS polyacrylamid gel 6 electrophoresis (PAGE). The gel was blotted and the indicated proteins were detected by 7 immunoblotting with indicated antibodies. (B) Nuclear translocation of STAT1 was tested as 8 described in the M&M section (C) Native protein lysates of uninfected, wt-MCMV-or 9
∆M27-infected cells treated with IFNα, IFNγ or left untreated were subjected to EMSA 10 analysis using a GAS probe as described in the M&M section. The identity of STAT1-11 containing complexes (indicated as 'GAF') was ensured by a super-shift upon addition of a 12 STAT1-specific antibody to a lysate of IFNγ-conditioned cells (compare lanes 1 and 4). (D) 13
Cells were either mock-or MCMV-infected (for 24 h with 10 PFU/cell) and subsequently 14 exposed to 100 U/ml IFNγ for 30 min. Cells were lysed and subjected to ChIP analysis as 15 described in the M&M section. (E) A clonal NIH3T3-based cell line harbouring a luciferase 16
reporter gene under the control of a GAS promoter/enhancer element was generated. Cells 17 were infected (10 PFU/cell) with the indicated viruses for 24 h and then IFN stimulated (100 18 U/ml) for 5 h. Afterwards, luciferase activity was quantified as described in the M&M 19 section. Arithmetic mean and standard deviation are depicted. Statistical significance was 20 tested using t-test (unpaired, two-sided) 
